MADISON, Wis.--(BUSINESS WIRE)--The Scientist named Promega NanoBiT™ (NanoLuc® Binary Technology) Assay as a Top 10 Innovation for 2015. This is the third Promega technology in four years named as a ...
The last two decades have witnessed the steady growth of the protein drug market. As original recombinant products come off patent, generics/ biosimilars are also beginning to be manufactured. The ...
Enables genome-wide screening of protein interactions through the co-expression of bait proteins with protein libraries. Membrane-Based Yeast Two-Hybrid Utilizes split-ubiquitin protein ...
This article is based on a poster originally authored by Sunidhi Shetty, Narasimha Murthy Bandaru, Anna Moberg and Marco Manni, which was presented at ELRIG Drug Discovery 2024 in affiliation with ...
The expert in complement therapeutics development, Creative Biolabs, keys the importance of complement function and activity tests in complement defect screening and drug development. The complement ...
Cell-based assays have become the rage once again, and there are a number of avenues for researchers to utilize to get the work they need done. At Cambridge Healthtech’s “World Pharmaceutical Congress ...
A comprehensive analysis of over 500,000 human protein variants reveals that 60% of disease-causing missense mutations reduce protein stability In a recent study published in Nature, researchers used ...
Targeted protein degradation (TPD) is a promising alternative to conventional small-molecule drugs. Rather than inhibiting a single enzyme’s function, degrader molecules label selected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback